Management of xerostomia related to radiotherapy for head and neck cancer

Alternate title: 
J2 - Oncology (Williston)
Secondary title: 
T2 - Oncology (Williston Park)
Short title: 
Management of xerostomia related to radiotherapy for head and neck cancer
Authors: 
Kahn, Shannon T.
Johnstone, Peter A. S.
Volume: 
19
Start page: 
1827-32; discussion 1832-4, 1837-9
Annotations: 
Type E, Priority 5
Date: 
Dec
Year: 
2005
Accession number: 
16506635
Database: 
MEDLINE RCTs
Number: 
M1 - 14
Serial: 
0890-9091
Type of work: 
M3 - Review
ID: 
12296
Notes: 
N1 - Kahn ST
Johnstone PA
Key words: 
Acupuncture Therapy
Amifostine/tu [Therapeutic Use]
Clinical Trials as Topic
*Head and Neck Neoplasms/rt [Radiotherapy]
Humans
Muscarinic Agonists/tu [Therapeutic Use]
Palliative Care
Pilocarpine/tu [Therapeutic Use]
Quinuclidines/tu [Therapeutic Use]
Radiation-Protective Agents/tu [Therapeutic Use]
Radiotherapy/ae [Adverse Effects]
Radiotherapy/mt [Methods]
Submandibular Gland/su [Surgery]
Thiophenes/tu [Therapeutic Use]
Xerostomia/et [Etiology]
*Xerostomia/th [Therapy]
0 (Muscarinic Agonists)
0 (Quinuclidines)
0 (Radiation-Protective Agents)
0 (Thiophenes)
01MI4Q9DI3 (Pilocarpine)
K9V0CDQ56E (cevimeline)
M487QF2F4V (Amifostine)
Types of evidence: 
Type E
Priorities of Care: 
Priority 5: Plan and do